1. Home
  2. INTT vs RFL Comparison

INTT vs RFL Comparison

Compare INTT & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

N/A

Current Price

$14.16

Market Cap

148.4M

Sector

Technology

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.11

Market Cap

133.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
INTT
RFL
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
148.4M
133.1M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
INTT
RFL
Price
$14.16
$1.11
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $20.00
N/A
AVG Volume (30 Days)
★ 122.2K
86.5K
Earning Date
11-06-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.23
EPS
★ 0.06
N/A
Revenue
★ $66,801,000.00
$917,000.00
Revenue This Year
$22.35
N/A
Revenue Next Year
$7.07
N/A
P/E Ratio
$263.00
★ N/A
Revenue Growth
★ 66.06
43.96
52 Week Low
$7.07
$1.09
52 Week High
$20.00
$3.96

Technical Indicators

Market Signals
Indicator
INTT
RFL
Relative Strength Index (RSI) 52.80 29.15
Support Level $12.54 N/A
Resistance Level $15.25 $1.38
Average True Range (ATR) 0.95 0.11
MACD 0.09 -0.00
Stochastic Oscillator 49.87 1.03

Price Performance

Historical Comparison
INTT
RFL

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: